RADX Cash From Financing

RADX Annual CFF

$19.59 M
+$13.38 M+215.82%

01 June 2024

RADX Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RADX Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+215.8%--
3 y3 years-58.5%--
5 y5 years-58.5%--

RADX Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-58.5%+215.8%
5 y5-year-58.5%+215.8%
alltimeall time-58.5%+215.8%

Radiopharm Theranostics Limited Cash From Financing History

DateAnnualQuarterlyTTM
June 2024
$19.59 M(+215.8%)
-
-
DateAnnualQuarterlyTTM
June 2023
$6.20 M(-86.9%)
-
-
June 2022
$47.21 M
-
-

FAQ

  • What is Radiopharm Theranostics Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for Radiopharm Theranostics Limited?
  • What is Radiopharm Theranostics Limited annual CFF year-on-year change?

What is Radiopharm Theranostics Limited annual cash flow from financing activities?

The current annual CFF of RADX is $19.59 M

What is the all time high annual CFF for Radiopharm Theranostics Limited?

Radiopharm Theranostics Limited all-time high annual cash flow from financing activities is $47.21 M

What is Radiopharm Theranostics Limited annual CFF year-on-year change?

Over the past year, RADX annual cash flow from financing activities has changed by +$13.38 M (+215.82%)